Literature DB >> 29155456

Identifying Sarcopenia in Female Long-Term Care Residents: A Comparison of Current Guidelines.

Mary P Kotlarczyk1, Subashan Perera1,2, David A Nace1, Neil M Resnick1, Susan L Greenspan1,3.   

Abstract

OBJECTIVES: To establish the prevalence of sarcopenia in a long-term care population, assess agreement among different consensus sarcopenia diagnostic criteria, and examine agreement of a self-reported questionnaire with consensus guidelines.
DESIGN: Cross-sectional secondary analysis.
SETTING: Long-term care communities in the greater Pittsburgh, Pennsylvania, area. PARTICIPANTS: Women aged 65 and older (mean 83.6) undergoing eligibility screening for a fracture reduction trial (N = 141). MEASUREMENTS: We measured appendicular lean muscle mass using dual-energy X-ray absorptiometry. Hand grip strength and usual gait speed were also evaluated. Sarcopenia status was determined according to European Working Group on Sarcopenia in Older People (EWGSOP) and the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project criteria and the SARC-F questionnaire.
RESULTS: Eleven participants were sarcopenic (7.8%) according to the EWGSOP criteria, six (4.3%) according to FNIH conservative cut-point guidelines, and 32.6% (n = 46) according to FNIH intermediate cut-points. Only 2 of 141 participants met criteria for sarcopenia according to all three guidelines. Sarcopenia was identified in 30 (21.3%) participants according to the SARC-F questionnaire. Sensitivity of the SARC-F with consensus panel definitions ranged from 18.2% to 33.3%. Specificity ranged from 78.7% to 81.1%.
CONCLUSION: Current consensus criteria from the EWGSOP and FNIH Sarcopenia Project do not agree and have little overlap in older female long-term care residents. The SARC-F questionnaire is a simple tool that could be implemented in long-term care, but it has low sensitivity compared with current consensus guidelines in the identification of sarcopenic individuals.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.

Entities:  

Keywords:  SARC-F; long-term care; sarcopenia

Mesh:

Year:  2017        PMID: 29155456      PMCID: PMC5809253          DOI: 10.1111/jgs.15213

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  28 in total

1.  Co-morbidity adjustment for functional outcomes in community-dwelling older adults.

Authors:  Sally K Rigler; Stephanie Studenski; Dennis Wallace; Dean M Reker; Pamela W Duncan
Journal:  Clin Rehabil       Date:  2002-06       Impact factor: 3.477

2.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

3.  Defining sarcopenia in terms of incident adverse outcomes.

Authors:  Jean Woo; Jason Leung; J E Morley
Journal:  J Am Med Dir Assoc       Date:  2014-12-23       Impact factor: 4.669

4.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

5.  Sarcopenia Screened With SARC-F Questionnaire Is Associated With Quality of Life and 4-Year Mortality.

Authors:  Tai-Yin Wu; Chen-Kun Liaw; Fang-Chun Chen; Kuan-Liang Kuo; Wei-Chu Chie; Rong-Sen Yang
Journal:  J Am Med Dir Assoc       Date:  2016-09-22       Impact factor: 4.669

6.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

Review 7.  Sarcopenia: pharmacology of today and tomorrow.

Authors:  Marco Brotto; Eduardo L Abreu
Journal:  J Pharmacol Exp Ther       Date:  2012-08-28       Impact factor: 4.030

8.  An evidence-based comparison of operational criteria for the presence of sarcopenia.

Authors:  Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

9.  Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.

Authors:  Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

10.  Grip strength cutpoints for the identification of clinically relevant weakness.

Authors:  Dawn E Alley; Michelle D Shardell; Katherine W Peters; Robert R McLean; Thuy-Tien L Dam; Anne M Kenny; Maren S Fragala; Tamara B Harris; Douglas P Kiel; Jack M Guralnik; Luigi Ferrucci; Stephen B Kritchevsky; Stephanie A Studenski; Maria T Vassileva; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  5 in total

1.  Application of SDOC Cut Points for Low Muscle Strength for Recovery of Walking Speed After Hip Fracture.

Authors:  Denise L Orwig; Jay Magaziner; Roger A Fielding; Hao Zhu; Ellen F Binder; Peggy M Cawthon; Shalender Bhasin; Rosaly Correa-de-Araujo; Todd Manini; Sheena Patel; Michelle Shardell; Thomas G Travison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

2.  Application of Cut-Points for Low Muscle Strength and Lean Mass in Mobility-Limited Older Adults.

Authors:  Gregory J Grosicki; Thomas G Travison; Hao Zhu; Jay Magaziner; Ellen F Binder; Marco Pahor; Rosaly Correa-de-Araujo; Peggy M Cawthon; Shalender Bhasin; Denise Orwig; Susan Greenspan; Todd Manini; Joe Massaro; Adam Santanasto; Sheena Patel; Roger A Fielding
Journal:  J Am Geriatr Soc       Date:  2020-07-07       Impact factor: 5.562

3.  Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF.

Authors:  Ming Yang; Jiaojiao Jiang; Yanli Zeng; Huairong Tang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

4.  Treatment of sarcopenia: the road to the future.

Authors:  John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-12       Impact factor: 12.910

5.  Prognostic utility of self-reported sarcopenia (SARC-F) in the Multiethnic Cohort.

Authors:  Anna H Wu; V Wendy Setiawan; Unhee Lim; Chiu-Cheng Tseng; Kami K White; John Shepherd; Heinz Josef Lenz; Iona Cheng; Daniel O Stram; Christopher Haiman; Lynne R Wilkens; Loïc Le Marchand
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-30       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.